-
Mashup Score: 9
With the advent of targeted agents and immunological therapies, the medical research community has become increasingly aware that conventional methods for determining the best dose or schedule of a new agent are inadequate. It has been well established that conventional phase I designs cannot reliab …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5Illumina Oncology - CGP for clinical trial enrollment - 3 month(s) ago
Richard Schilsky, MD, explains how comprehensive genomic profiling is qualifying patients with cancer to participate in clinical trials that provide treatmen…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Breakthrough: ASCO in Asia | ASCO Breakthrough - 11 month(s) ago
Your PrivacyASCO is committed to transparency regarding our websites and the ways we process data. When you visit our site, we may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences, your location, or your device and is mostly used to make the site work as you expect it to and to personalize your web experience with…
Source: conferences.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0ASCO Data Library - 1 year(s) ago
ASCO maintains an expansive repository of information that qualified individuals and organizations may request for research purposes.
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet-
The @ASCO #COVID19 Registry has data on 1000s of patients with cancer who got COVID-19. It is available on @ASCO's data library (https://t.co/ygSgt7VmYg). Submit an application to access the registry data to answer your own research questions on patients with cancer and COVID-19. https://t.co/tzu8yLzsWU
-
-
Mashup Score: 0
This Medical News article discusses US initiatives to improve health care worker well-being as burnout and intent to leave to medicine reach record levels.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2ASCO COVID-19 Registry Data Dashboard - 1 year(s) ago
Visualization of data submitted through ASCO’s Survey on COVID-19 in Oncology Registry
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1ASCO Data Library - 1 year(s) ago
ASCO maintains an expansive repository of information that qualified individuals and organizations may request for research purposes.
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Director, Oncology Biostatistics - 1 year(s) ago
Are you interested in making a world of difference in cancer care? Cancer strikes more than 10 million people worldwide each year. As the leading medical society representing doctors who care for people with cancer, the American Society of Clinical Oncology (ASCO) is committed to conquering cancer through research, education, and promotion of the highest quality, equitable patient care. Who we…
Source: asco.wd5.myworkdayjobs.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
The American Society of Clinical Oncology (ASCO) and Association of Community Cancer Centers (ACCC) joined forces to ensure that cancer clinical trials better reflect the diversity of people with cancer. After receiving ideas from the oncology community, and pilot testing resources, ASCO and ACCC recently released influential, free, and practical resources for research sites to help make changes…
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
The American Society of Clinical Oncology (ASCO) and Association of Community Cancer Centers (ACCC) joined forces to ensure that cancer clinical trials better reflect the diversity of people with cancer. After receiving ideas from the oncology community, and pilot testing resources, ASCO and ACCC recently released influential, free, and practical resources for research sites to help make changes…
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet
Recently published online (early access) in Clinical Trials. Grateful to co-editors of Special Issue on Dose Optimization, especially Peter Thall, whose good humor & wit made the work more enjoyable. Stay tuned for full issue! #doseoptimization @SCTorg https://t.co/7Rdd2EJ88U https://t.co/fQtgsUsepj